Why Lilly’s Bid for Verve Therapeutics Sent the Stock Soaring...
Shares in Verve Therapeutics (NASDAQ: VERV) soared 80.5% this week on the news of an agreement for Eli Lilly (NYSE: LLY) to acquire Verve. The deal centers on an exciting...
Tag: Verve Therapeutics
2 results found
Lilly to buy gene-editing partner Verve for up to $1.3...
By Christy Santhosh and Sriparna Roy (Reuters) -Eli Lilly will acquire gene-editing startup Verve Therapeutics for up to $1.3 billion, the companies said on Tuesday, accelerating a push into experimental...
